MAAPC’s conference has been approved for 7 PHARMACOLOGY CEs, join us April 22, 2023
Posted about 2 months ago by Elaine Crain
DEA Requirement Update
The Consolidated Appropriations Act of 2023 stipulates an eight-hour training requirement for all DEA-registered practitioners on the treatment and management of patients with opioid or other substance use disorders.
MAAPC is offering 4 CE credits this spring that meet this requirement and Maryland’s 2018 requirement for applicants registering for new or renewing CDS registration (Safe Prescribing of Opioids)
Join us on April 22nd at Anne Arundel Community College for Pharmacology Update 2023 featuring:
- Don D’Aquila, PharmD—How Much Morphine is That? Opioid Conversions & Calculations
- Kelli Goldsborough, CRNP— Treating Pain in Opioid Addicted Patients
And on-line presentations featuring:
- Sarah Merritt, MD – CDC Guidelines of Prescribing Opiates for Pain: 2022 Changes
- Shana Metzger – Recognition. Diagnosis & Management of Opioid Use Disorder
Consolidated Appropriations Act of 2023 requirement: a one-time eight-hour training requirement for all DEA-registered practitioners on the treatment and management of patients with opioid or other substance use disorders.
This act requires all renewing and new DEA applicants to testify that they have completed 8 CE hours on the treatment and management of patients with opioid or other substance use
disorders beginning on June 27, 2023.
- The training does not have to occur in one session.
- This is a one-time training requirement affirmation.
- There are a couple of exceptions, so read the DEA's letter if you are a specialty provider or a new graduate.
Consider becoming a member of your professional organization today and keep our profession vibrant & essential!